Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

RecruitingOBSERVATIONAL
Enrollment

1,200

Participants

Timeline

Start Date

May 21, 2019

Primary Completion Date

September 30, 2025

Study Completion Date

December 31, 2025

Conditions
CancerLiver CirrhosisChronic HepatitisHepatitis BHepatitis CDiabetesCOPD
Interventions
DIAGNOSTIC_TEST

Multi-analyte Blood Test

Intend for the qualitative detection of DNA methylation markers for the detection of various types of cancer

Trial Locations (7)

38104

RECRUITING

Methodist LeBonheur Healthcare, Memphis

55407

RECRUITING

VPCI Oncology Research, Minneapolis

55432

RECRUITING

Virginia Piper Cancer Institute Mercy Hospital-Unity Campus, Fridley

55433

RECRUITING

Allina Health, Virginia Piper Cancer Institute, Coon Rapids

75082

RECRUITING

Methodist Hospital, Richardson

75234

RECRUITING

Liver Center of Texas, Dallas

90277

ACTIVE_NOT_RECRUITING

Torrance Memorial Physician Network - Cancer Care, Redondo Beach

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Helio Genomics

INDUSTRY